We founded ORPEGEN GmbH October 1, 1982.
January 1, 2015, Corden Pharma Internation GmbH [ CPI ] in an asset deal acquired the chemical and contract R & D operations of ORPEGEN Peptide Chemicals. However, 2016 CPI dislocated the entire R & D part including the according personnel to Frankfurt/ M – Fechenheim.
2016, the chemical plant in Heidelberg became shut-down by CPI. The entire cold house stock of amino acid derivatives and peptides however, once manufactured GMP-based by ORPEGEN Pharma and its successor, ORPEGEN Peptide Chemicals GmbH, remained operative in Heidelberg under the direction of the owner and CEO, Prof. Birr.
We are continuing the OPC operations in selling and trading our valuable products ex stock worldwide. When demanded by specific chemical requirements we are cooperating also with German and other contract manufacturers to serve our customers needs. We are maintaining our close contractual relations with CPI GmbH regarding GMP-based peptide drugs, in particular when the according API manufacture should be based on ORPEGEN know-how.